1. Home
  2. RNXT vs HIT Comparison

RNXT vs HIT Comparison

Compare RNXT & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • HIT
  • Stock Information
  • Founded
  • RNXT 2012
  • HIT 1964
  • Country
  • RNXT United States
  • HIT United States
  • Employees
  • RNXT N/A
  • HIT N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • HIT Specialty Insurers
  • Sector
  • RNXT Health Care
  • HIT Finance
  • Exchange
  • RNXT Nasdaq
  • HIT Nasdaq
  • Market Cap
  • RNXT 44.6M
  • HIT 37.2M
  • IPO Year
  • RNXT 2021
  • HIT 2024
  • Fundamental
  • Price
  • RNXT $1.40
  • HIT $0.61
  • Analyst Decision
  • RNXT Strong Buy
  • HIT
  • Analyst Count
  • RNXT 2
  • HIT 0
  • Target Price
  • RNXT $7.00
  • HIT N/A
  • AVG Volume (30 Days)
  • RNXT 210.6K
  • HIT 712.4K
  • Earning Date
  • RNXT 05-15-2025
  • HIT 04-14-2025
  • Dividend Yield
  • RNXT N/A
  • HIT N/A
  • EPS Growth
  • RNXT N/A
  • HIT N/A
  • EPS
  • RNXT N/A
  • HIT 0.02
  • Revenue
  • RNXT $240,000.00
  • HIT $22,380,959.00
  • Revenue This Year
  • RNXT $3,927.91
  • HIT $58.79
  • Revenue Next Year
  • RNXT $219.75
  • HIT N/A
  • P/E Ratio
  • RNXT N/A
  • HIT $33.30
  • Revenue Growth
  • RNXT N/A
  • HIT 11.24
  • 52 Week Low
  • RNXT $0.75
  • HIT $0.51
  • 52 Week High
  • RNXT $1.69
  • HIT $7.59
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 78.13
  • HIT N/A
  • Support Level
  • RNXT $1.17
  • HIT N/A
  • Resistance Level
  • RNXT $1.30
  • HIT N/A
  • Average True Range (ATR)
  • RNXT 0.08
  • HIT 0.00
  • MACD
  • RNXT 0.02
  • HIT 0.00
  • Stochastic Oscillator
  • RNXT 100.00
  • HIT 0.00

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

Share on Social Networks: